by University College London Cardiac amyloidosis improvement demonstrated by Cardiovascular Magnetic Resonance (CMR) Extracellular Volume Mapping (ECV) for amyloid. Baseline scan on top row; after six months of chemotherapy mid row; and one year after chemotherapy bottom row. There are progressive reductions in CMR (identified as T1 – column two) and ECV (column four) over...
